Mankind Pharma Ltd. Financials: Quarterly Results
Revenue
3639.95
Cr.
PAT
410.67
Cr.
EBITDA
769.58
Cr.
Mankind Pharma Ltd. Q3FY26 Financial Metrics
| Indicator | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 |
|---|---|---|---|---|---|
| Net Sales/Income from operations (Cr.) | 3567.20 | 3697.16 | 3570.35 | 3079.37 | 3230 |
| Total Income From Operations (Cr.) | 3567.20 | 3697.16 | 3570.35 | 3079.37 | 3230 |
| P/L Before Interest, Excpt. Items & Tax (Cr.) | 769.58 | 791.38 | 707.97 | 703.65 | 714.82 |
| P/L Before Exceptional Items & Tax (Cr.) | 612.38 | 621.70 | 537.32 | 513.11 | 493.89 |
| P/L After Tax from Ordinary Activities (Cr.) | 410.67 | 517.86 | 441.45 | 426.67 | 381.08 |
| Net Profit/Loss For the Period (Cr.) | 410.67 | 517.86 | 441.45 | 422.33 | 381.08 |
| Basic EPS | 9.90 | 12.39 | 10.62 | 10.20 | 9.45 |
FAQs
Mankind Pharma Ltd. announced its quarterly results for Q3 FY2026 on February 3, 2026.
In Q3 FY2026, Mankind Pharma Ltd. are as follows:
Revenue: ₹3639.95 crore
Net Profit: ₹410.67 crore.
For Q3 FY2026, Mankind Pharma Ltd. posted ₹3639.95 crore in revenue and ₹410.67 crore in net profit.
Past quarterly results for Mankind Pharma Ltd. can be found on their official Investor Relations page, which includes detailed reports and financial performance summaries.